Catalent Inc Business Finance Contracts & Agreements
52 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (5)
- Exchange Agreements (2)
- Indenture Agreements (6)
- Purchase Agreements (1)
- Registration Rights Agreements (4)
- Share Agreements (8)
- Stock Agreements (16)
- Underwriting Agreements (9)
- Amendment to Registration Rights Agreement, dated as of April 17, 2024, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP... (Filed With SEC on September 6, 2024)
- Long Term International Assignment Letter, dated October 10, 2022, by and between Catalent Pharma Solutions LLC and Manja Boerman (Filed With SEC on December 8, 2023)
- Form of Restricted Stock Unit Agreement for Non-Employee Directors (Filed With SEC on December 8, 2023)
- Amendment No. 10 to Amended and Restated Credit Agreement, dated as of November 22, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Filed With SEC on November 27, 2023)
- Amendment No. 9 to Amended and Restated Credit Agreement, dated as of September 27, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Filed With SEC on September 28, 2023)
- Form of Restricted Stock Unit Agreement for non-U.S. Non-Employee Directors (fiscal 2023) (Filed With SEC on November 1, 2022)
- Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (fiscal 2023) (Filed With SEC on November 1, 2022)
- Description of the Companys Common Stock, par value $0.01 per share (Filed With SEC on November 1, 2022)
- Indenture, dated September 29, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on September 29, 2021)
- Membership Interest Purchase Agreement, dated August 29, 2021, by and among Catalent Pharma Solutions, Inc., Bettera Holdings, LLC, the members of Bettera Holdings, LLC, and... (Filed With SEC on August 30, 2021)
- Indenture, dated February 22, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on February 22, 2021)
- Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (Filed With SEC on August 31, 2020)
- Underwriting Agreement, dated June 10, 2020, between the Company and RBC Capital Markets, LLC (Filed With SEC on June 15, 2020)
- Indenture, dated March 2, 2020, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, Deutsche Trustee Company Limited, as trustee, Deutsche Bank... (Filed With SEC on March 3, 2020)
- Underwriting Agreement, dated February 3, 2020, among the Company, J.P. Morgan Securities LLC and UBS Securities LLC (Filed With SEC on February 6, 2020)
- Stock Purchase Agreement, dated as of February 2, 2020, among Catalent Pharma Solutions, Inc., Orgenesis Inc. and GPP-II Masthercell, LLC (Filed With SEC on February 3, 2020)
- Description of the Companys Common Stock, par value $0.01 (Filed With SEC on August 27, 2019)
- Indenture, dated June 27, 2019, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on June 27, 2019)
- Registration Rights Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A... (Filed With SEC on May 22, 2019)
- Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (three-year performance period) (Filed With SEC on May 7, 2019)
- Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (three-year performance period) (Filed With SEC on May 7, 2019)
- Form of 2018 OIP Restricted Stock Unit Agreement for Non-U.S. Employees (Filed With SEC on May 7, 2019)
- Form of 2018 OIP Restricted Stock Unit Agreement for U.S. Employees (Filed With SEC on May 7, 2019)
- Equity Commitment and Investment Agreement, dated as of April 14, 2019, by and among Catalent, Inc. Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P.... (Filed With SEC on April 17, 2019)
- Catalent, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on November 6, 2018)
- Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)
- Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)
- Form of the Performance Share Unit Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)
- Form of the Performance Share Unit Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)
- Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2017 through June 30, 2020) (Filed With SEC on August 28, 2018)
- Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2017 through June 30, 2020) (Filed With SEC on August 28, 2018)
- Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2016 through June 30, 2019) (Filed With SEC on August 28, 2018)
- Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2016 through June 30, 2019) (Filed With SEC on August 28, 2018)
- Underwriting Agreement, dated July 24, 2018, between the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the... (Filed With SEC on July 27, 2018)
- Form of the Performance Share Unit Agreement for Non-U.S. Employees for the performance period July 1, 2017 through June 30, 2020 (Filed With SEC on November 6, 2017)
- Form of the Performance Share Unit Agreement for U.S. Employees for the performance period July 1, 2017 through June 30, 2020 (Filed With SEC on November 6, 2017)
- Amendment No. 3 to Amended and Restated Credit Agreement, dated as of October 18, 2017, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley... (Filed With SEC on October 18, 2017)
- Indenture, dated October 18, 2017, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on October 18, 2017)
- Underwriting Agreement, dated September 26, 2017, between the Company, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and RBC Capital Markets, LLC, as representatives of the... (Filed With SEC on September 29, 2017)
- Interest Purchase Agreement, dated September 18, 2017, by and among Catalent Pharma Solutions, Inc., Cook Pharmica LLC, Cook Group Incorporated, and, solely for purposes of... (Filed With SEC on September 19, 2017)
